Agios Pharmaceuticals
(AGIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,504 | -39,407 | -20,102 | -23,706 | N/A |
| Depreciation Amortization | 1,905 | 1,724 | 1,466 | 1,192 | N/A |
| Income taxes - deferred | N/A | 3,842 | 6,707 | -10,660 | N/A |
| Accounts receivable | -6,016 | -476 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,577 | 30 | -322 | 809 | N/A |
| Other Working Capital | -19,260 | -25,589 | -38,371 | 17,584 | N/A |
| Other Operating Activity | 9,945 | 3,476 | 1,074 | -438 | 0 |
| Operating Cash Flow | $-59,353 | $-56,400 | $-49,548 | $-15,219 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,216 | -1,294 | -1,475 | -1,906 | N/A |
| Purchase Of Investment | -837,219 | -146,049 | -88,524 | -105,936 | N/A |
| Sale Of Investment | 505,528 | 60,126 | 113,041 | 85,482 | N/A |
| Other Investing Activity | 571 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-333,336 | $-87,217 | $23,042 | $-22,360 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 335,880 | 113,517 | 142 | 57 | N/A |
| Other Financing Activity | -720 | 10,363 | 0 | 77,301 | 0 |
| Financing Cash Flow | $335,160 | $123,880 | $142 | $77,358 | $N/A |
| Beginning Cash Position | 71,560 | 91,297 | 117,661 | 77,882 | N/A |
| End Cash Position | 14,031 | 71,560 | 91,297 | 117,661 | N/A |
| Net Cash Flow | $-57,529 | $-19,737 | $-26,364 | $39,779 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,353 | -56,400 | -49,548 | -15,219 | N/A |
| Capital Expenditure | -2,216 | -1,294 | -1,475 | -1,906 | N/A |
| Free Cash Flow | -61,569 | -57,694 | -51,023 | -17,125 | 0 |